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Intermittent mildly stressful situations provide opportunities to learn, practice, and improve coping in a
process called stress inoculation. Stress inoculation also enhances cognitive control and response inhi-
bition of impulsive motivated behavior. Cognitive control and motivation have been linked to striatal
dopamine D2 and/or D3 receptors (DRD2/3) in rodents, monkeys, and humans. Here, we study squirrel
monkeys randomized early in life to stress inoculation with or without maternal companionship and a
no-stress control treatment condition. Striatal DRD2/3 availability in adulthood was measured in vivo by
[11C]raclopride binding using positron emission tomography (PET). DRD2/3 availability was greater in
caudate and putamen compared to ventral striatum as reported in PET studies of humans and other non-
human primates. DRD2/3 availability in ventral striatumwas also consistently greater in stress inoculated
squirrel monkeys compared to no-stress controls. Squirrel monkeys exposed to stress inoculation in the
presence of their mother did not differ from squirrel monkeys exposed to stress inoculation without
maternal companionship. Similar effects in different social contexts extend the generality of our ﬁndings
and together suggest that stress inoculation increases striatal DRD2/3 availability as a correlate of
cognitive control in squirrel monkeys.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Intermittent exposure to mildly stressful situations is a feature
of stress inoculation training for people who work in conditions
where performance in the face of adversity is required, e.g., medical
and military personnel, police, ﬁreﬁghters, and rescue workers
(Meichenbaum, 1993; Saunders et al., 1996; Stetz et al., 2007).
Stress inoculation is further supported by evidence that mild but
not minimal nor severe stress exposure promotes subsequent
coping and emotion regulation as described by U-shaped functions
(Russo et al., 2012; Sapolsky, 2015; Seery et al., 2010). Exposure
psychotherapies likewise teach patients to imagine a graded series
of stressful situations and encourage interaction with stressors
in vivo (McNally, 2007). These procedures promote learning (Craske
et al., 2008) and provide opportunities to practice acquired copingnd Behavioral Sciences, 1201
ool of Medicine, Stanford, CA
s).
Inc. This is an open access article uskills (Serino et al., 2014).
Previously, we showed that stress inoculation early in life en-
hances subsequent coping and emotion regulationmodeled inmice
(Brockhurst et al., 2015) and squirrel monkeys (Lyons et al., 2009;
Lyons et al., 2010). In keeping with suggestions that emotion
regulation is an aspect of cognitive control (Compton et al., 2011),
we also found that stress inoculation enhances cognitive control of
impulsive motivated behavior (Parker et al., 2005; Parker et al.,
2012). Impaired cognitive control and dysregulation of motivation
have been linked to low striatal dopamine D2 and/or D3 receptor
(DRD2/3) levels in rodents, monkeys, and humans (Dalley et al.,
2011; Groman et al., 2011; Nader et al., 2006; Triﬁlieff &
Martinez, 2014; Volkow et al., 2011). Conversely, increased exper-
imental expression of dopamine D2 receptors in ventral striatum
enhances motivation in mice (Triﬁlieff et al., 2013). High striatal
DRD2/3 availability in humans is associated with resilience against
the development of addictions (Volkow et al., 2002; Volkow et al.,
2006) and pharmacological DRD2/3 agonists decrease impulsive
behavior in rats (Fernando et al., 2012). DRD2/3 agonists similarly
improve reversal learning as an index of cognitive control innder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Here, we examine striatal DRD2/3 regulation by stress inocula-
tion in female squirrel monkeys. Females are studied because
stress-related mental health disorders are 2e3 times more com-
mon in women than men (Altemus et al., 2014). Impaired cognitive
control of thoughts, feelings, and behavior is a key dimension of
various psychiatric disorders in humans (Groman & Jentsch, 2012)
and neural mechanisms that mediate this dimension may provide
novel targets for new treatment interventions. Based on our ﬁnd-
ings that cognitive control of impulsivity is improved in squirrel
monkeys exposed early in life to stress inoculation (Parker et al.,
2005; Parker et al., 2012), we test for increased striatal DRD2/3
availability in stress inoculated squirrel monkeys studied as adults
by measuring [11C]raclopride binding in vivo with positron emis-
sion tomography (PET).
2. Materials and methods
Female squirrel monkeys (Samiri sciureus) that were born and
raised at the Stanford University Research Animal Facility served as
subjects. All squirrel monkeys were initially housed in undisturbed
mixed-sex natal groups through 16 weeks of age. Group composi-
tion was determined by birth dates to minimize developmental
differences between natal groups. Seasonal synchronous breeding
facilitated the generation of age-matched groups.
Groups were housed indoors in 1.8  1.2  1.8 m species
appropriate cages that were cleaned daily. Housing and testing
occurred in climate controlled rooms with an ambient temperature
of 26 C. Light/dark cycles were 12:12 h with lights on at 0700 h. All
squirrel monkeys were provided unrestricted access to fresh
drinking water and monkey chow with fruit and vegetable sup-
plements. Various toys, swinging perches, and simulated foraging
activities were provided for environmental enrichment. To facili-
tate husbandry-related activities and experimental manipulations,
squirrel monkeys were trained to leave the home cage through a
small sliding door connected to a transport box used for capture
and transportation. All procedures were approved by Stanford
University's Administrative Panel on Laboratory Animal Care and
were carried out in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
2.1. Experimental design
Squirrel monkeys were randomized to one of three 10-week
treatment conditions that occurred between 17 and 27 week of
age as described elsewhere in detail (Parker et al., 2004; Parker
et al., 2006). In the no-stress (NS) control condition, squirrel
monkeys were continuously maintained in undisturbed natal
groups. In the stress inoculation (SI) condition, squirrel monkeys
were individually removed from natal groups once each week for
10 total 1-hr separation sessions (Parker et al., 2004). In the
SI þ Mom condition, squirrel monkeys were treated identically
except that each monkey along with its mother was removed
together from natal groups once each week for 10 total 1-hr ses-
sions (Parker et al., 2006). After each social separation in the SI and
SI þMom conditions, squirrel monkeys were returned to the home
cage and reunited with the natal group. All separations occurred
between 1200 and 1800 h and no more than one squirrel monkey
from each natal group was separated on a given day.
After completion of the treatment conditions at 27 week of age,
behavioral measures of coping and emotion regulation were
collected from all squirrel monkeys in the presence of mothers
during involuntary exposure to a novel environment at 9 months of
age (Parker et al., 2004; Parker et al., 2006). Mothers were then
permanently removed and their offspring were housed with peers.Cognitive control of impulsive behavior was examined in NS and SI
squirrel monkeys at 1.5 and 3.5 years of age (Parker et al., 2005;
Parker et al., 2012). Novelty seeking was also assessed in NS and
SI squirrel monkeys at 2.5 years of age (Parker et al., 2007). Mag-
netic resonance imaging (MRI) of brainwas conducted with NS and
SI squirrel monkeys at 3.3 years of age (Katz et al., 2009) and place
preference conditioning tests of NS and SI squirrel monkeys were
conducted at 4.4 years of age (unpublished observations). Cognitive
control, novelty seeking, place preference conditioning, and pre-
vious neuroimaging procedures were not conducted with
SIþMom squirrel monkeys and provided the opportunity to assess
stress inoculation versus subsequent testing effects. After 4.4 years
of age, no tests were conducted with any of the squirrel monkeys
except for procedures described below.
All females were housed separately from males in same-sex
social groups beginning at puberty around 2.5 years of age to pre-
vent breeding. Striatal DRD2/3 availability was assessed in vivowith
PET using [11C]raclopride in 24 randomly selected females from the
3 rearing conditions: 9 NS, 7 SI, and 8 SI þ Mom females at 11.2
years of age (range 10.5e11.7 years). Lifespan in captivity is ~20
years (Brady, 2000). All neuroimaging was conducted during non-
breeding seasons when sex hormone levels remain stable at non-
detectable levels in these seasonally breeding primates (Schiml
et al., 1999).
2.2. [11C]raclopride radiosynthesis
[11C]raclopride was prepared in a GE TRACERlab FX C Pro
module (GE Healthcare) using previously published methods
(Langer et al., 1999) with the following modiﬁcations. Brieﬂy, [11C]
carbon dioxide was delivered from a GE PETtrace cyclotron (GE
Healthcare) into the synthetic module, where the methylating
agent [11C]methyl triﬂate, was formed from [11C]carbon dioxide via
reduction, halogenation, and triﬂation. [11C]Methyl triﬂate was
bubbled with a ﬂow rate of 20 mL/min into solution containing
acetone (300 ml), O-Desmethyl free base precursor (1 mg, 3.3 mmol,
ABX), and NaOH (3 mL, 1 N) at 20 C. The reaction mixture was
warmed to room temperature within 1 min, diluted with 1 mL
water, and loaded on a semi-preparative HPLC column for puriﬁ-
cation (Phenomenex Luna C18 5 micro, 250  10 mm, 30% aceto-
nitrile, 70% 0.1 M NH4HCO2 with 0.5% AcOH, 7 mL/min). The
fraction corresponding to [11C]raclopride (Rt ¼ 9.2 min) was
collected in a round ﬂask preloaded with 20 mL water. Mobile
phase was removed using a solid phase extraction (SPE) process,
then [11C]raclopridewas eluted from the SPE cartridgewith ethanol
and subsequent dilution with saline (ethanol < 10% v/v). Final [11C]
raclopride for imaging was sterilized by passing it through a
0.22 mmMillexMP (33mm) sterile ﬁlter. Overall synthesis timewas
45 min and radiochemical yield of [11C]raclopride was 2.0 ± 0.6%
(n ¼ 40). Analytical HPLC (Phenomenex Gemini C18 5 micro,
250  4.6 mm, 60% acetonitrile, 40% 0.1 M NH4HCO2 with 0.5%
AcOH, 1 mL/min) showed the ﬁnal product (Rt ¼ 7.8 min) to have
>99% radiochemical and chemical purities and high speciﬁc activity
(10.6 ± 3.9 Ci/mmol; n ¼ 40). Both radiochemical yield and speciﬁc
activity were decay-corrected to the end of synthesis.
2.3. Neuroimaging
Whole brain anatomical and [11C]raclopride data were acquired
with established methods. Each squirrel monkey was fasted over-
night and then sedatedwith an intramuscular injection of 10mg/kg
ketamine hydrochloride. Atropine sulfate was subcutaneously
administered at 0.04 mg/kg. Ophthalmic ointment was placed in
both eyes and anesthesia was induced with ~1% isoﬂurane gas.
Heart rate, respiration, body temperature, and blood oxygen
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was placed using aseptic technique in either the cephalic or
saphenous vein. The radiotracer was produced to provide ~2.0 mCi
of [11C]raclopride in a volume no greater than 0.75 mL injected at
0.2 mL per 30 s at ~10:00 h. The mass (0.17 ± 0.02 mg; mean ± SEM)
and speciﬁc activity (4.3 ± 0.3 Ci/mmol) of [11C]raclopride admin-
istered to each monkey did not differ signiﬁcantly across the three
treatment conditions. After administration, the catheter was
ﬂushed with an amount of heparinized saline equivalent to the
volume of the catheter.
Fully three-dimensional dynamic emission data were then
collected for 60 min on a microPET R4 (Siemens Preclinical Solu-
tions, Knoxville, TN) using an energy window of 250e750 keV and
137 successive time frames of increasing duration (14 at 5 s, 29 at
10 s, 45 at 20 s, 30 at 40 s, 19 at 60 s). The microPET scanner has 96
scintillation detector modules compactly arranged in a 14.8 cm
diameter ring with an axial length of 7.8 cm. The tomograph has a
spatial resolution of 1.85 mm full-width at half-maximum (FWHM)
in the axial direction and 1.66 mm FWHM in the transaxial direc-
tion, which provides linear resolution of ~2.5 mm in all three di-
mensions. Resulting emission data were used to compute [11C]
raclopride binding for each voxel with a simpliﬁed kinetic model
that uses the cerebellum as a reference brain region devoid of
DRD2/3 (Gunn et al., 1997).
Whole brain anatomical data were acquired with MRI in sepa-
rate sessions on a Signa 3T scanner (General Electric, Milwaukee,
WI) at 9.5 years of age (range 8.4e10.3 years). Squirrel monkeys
were sedated as described above and MRI was conducted with the
following three-dimensional inversion recovery prepared fast
spoiled gradient pulse sequence: TR ¼ 12 ms, TE ¼ 3 ms,
TI ¼ 300 ms, ﬂip angle ¼ 15, NEX ¼ 4, matrix ¼ 160  160,
FOV ¼ 8 cm, voxel size ¼ 0.5  0.5  0.5 mm, slice
thickness¼ 0.5mm, gap¼ 0mm, total scan time¼ 18min. PET data
were spatially co-registered to MRI data (Fig. 1) using SPM8 soft-
ware (www.ﬁl.ion.ucl.ac.uk/spm/). [11C]raclopride binding mea-
sures (BPND) were determined for dorsal caudate nucleus, dorsalFig. 1. Axial (top) and coronal (bottom) images of neuroanatomy (MRI) and DRD2/3 avaputamen, and ventral striatum as deﬁned elsewhere (Mawlawi
et al., 2001).
2.4. Data analysis
Mixed factor analysis of variance (ANOVA) was used to assess
BPND measures. Stress inoculation (NS, SI, SI þ Mom) was consid-
ered a between-subjects factor with striatal region (caudate, pu-
tamen, ventral striatum) and brain side (left, right) considered
within-subjects factors. Body weight was included as a statistical
covariate in keeping with suggestions for small primate PET neu-
roimaging (Morris et al., 1998).
Post hoc pairwise comparisons with the NS control treatment
condition were conducted with Dunnett tests. Post hoc compari-
sons between striatal regions were conducted with Bonferroni
corrections and comparisons between SI and SI þ Mom treatment
conditions were conducted with t-tests. Effect sizes were deter-
mined using Cohen's d and associations between DRD2/3 BPND
measures and previously reported cognitive control errors (Parker
et al., 2012) were assessed with Pearson correlation coefﬁcients.
All test statistics were evaluated with two-tailed probabilities at
P < 0.05.
3. Results
Signiﬁcant stress inoculation (F(2,20) ¼ 4.01, P ¼ 0.034) and
striatal region (F(2,40) ¼ 37.61, P < 0.001) main effects were dis-
cerned in the 3-way ANOVA. As expected, DRD2/3 BPND was greater
in caudate and putamen compared to ventral striatum (P < 0.001).
Across striatal regions, DRD2/3 BPND was respectively 9.3% and
10.7% greater in SI and SI þMom squirrel monkeys compared to NS
controls. Laterality main effects and all of the interactions were not
statistically signiﬁcant.
The 3-way ANOVAwas decomposed to separately examine each
striatal region with left and right brain sides combined (Fig. 2).
Signiﬁcant stress inoculation effects were discerned for ventralilability (PET) detected in vivo by [11C]raclopride binding in squirrel monkey brain.
Fig. 2. Stress inoculation effects on DRD2/3 availability in ventral striatum, caudate, and putamen. Data from individual squirrel monkeys are plotted for the no-stress control (NS),
stress inoculated alone (SI), and stress inoculated with mother (SI þ Mom) treatment conditions. Horizontal bars signify treatment condition means and asterisks represent
signiﬁcant Dunnett test comparisons with the NS control condition (P < 0.05). DRD2/3 BPND measures reﬂect left and right brain sides combined. Note different y-axis measurement
scales for ventral striatum compared to caudate and putamen.
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P ¼ 0.048) but not putamen. Squirrel monkeys from the SI condi-
tion did not differ from SI þ Mom squirrel monkeys in any of the
striatal regions. Post hoc Dunnett tests established that DRD2/3
BPND was greater in ventral striatum for both SI (P ¼ 0.041) and
SI þ Mom (P ¼ 0.037) squirrel monkeys compared to NS controls.
Dunnett tests likewise established that DRD2/3 BPND was greater
for SI þMom squirrel monkeys compared to NS controls in caudate
(P ¼ 0.038) but not putamen (Fig. 2).
Effect size estimates conﬁrmed that DRD2/3 regulation by stress
inoculation varied systematically across striatal regions. For the SI
and SI þ Mom conditions combined, treatment effects relative to
the NS condition were greatest in ventral striatum (d ¼ 1.41) fol-
lowed by caudate (d ¼ 1.07) and putamen (d ¼ 0.78). Differences
between regions diminished the overall increase described above
for stress inoculation main effects across striatal regions. Effects in
ventral striatumwere the most robust with DRD2/3 BPND measures
respectively 22.1% and 21.8% greater in SI and SI þ Mom squirrel
monkeys compared to NS controls.
Behavioral assessments of cognitive control from an earlier
study (Parker et al., 2012) were completed for 6 of 7 SI squirrel
monkeys and 7 of 9 NS squirrel monkeys. Cognitive control tests
were not conducted with any of the SI þ Mom squirrel monkeys.
Similar DRD2/3 BPND measures in SI and SI þ Mom squirrel mon-
keys suggest that increased DRD2/3 availability relative to NS
controls (Fig. 2) reﬂects stress inoculation and not subsequent
testing effects.
Cognitive control errors for SI and NS squirrel monkeys analyzed
together were inversely correlated with bilateral measures of
DRD2/3 availability in ventral striatum (r ¼ 0.62, df 11, P ¼ 0.02)
but not caudate (r¼0.45, df 11, P ¼ 0.12) nor putamen (r¼0.32,
df 11, P ¼ 0.29). Higher DRD2/3 availability in ventral striatum
correlated with fewer cognitive control errors (Fig. 3) and the
correlation largely reﬂects group differences between SI and NS
squirrel monkeys. The correlation was nearly signiﬁcant, however,
for NS squirrel monkeys analyzed alone (r ¼ 0.71, df 5, P ¼ 0.076)
but not for SI squirrel monkeys with higher overall levels of DRD2/3
availability and fewer cognitive control errors.Fig. 3. Correlation between DRD2/3 availability in ventral striatum and cognitive
control errors (r ¼ 0.62, df 11, P ¼ 0.02) for squirrel monkeys from the no-stress
control (NS, triangles) and stress inoculated alone (SI, squares) treatment conditions.
Cognitive control errors were assessed as described elsewhere (Parker et al., 2012) and
represent the number of straight reaches on test trials with the box opening oriented
left or right. DRD2/3 BPND for ventral striatum reﬂects left and right brain sides
combined. Linear regression and 95% conﬁdence intervals are depicted.4. Discussion
Signiﬁcant stress inoculation and striatal region main effects for
DRD2/3 availability were detected in vivo by neuroimaging. DRD2/3
availability was greater in caudate and putamen compared to
ventral striatum. DRD2/3 availability in ventral striatum was alsoconsistently greater in stress inoculated squirrel monkeys
compared to no-stress controls. Squirrel monkeys exposed to stress
inoculation in the presence of their mother did not differ from
squirrel monkeys exposed to stress inoculation without maternal
companionship. Similar effects in different social contexts extend
the generality of our ﬁndings and together suggest that stress
inoculation increases striatal DRD2/3 availability as a correlate of
cognitive control in squirrel monkeys.
In natural and semi-natural conditions squirrel monkey
mothers and other group members intermittently leave newly
weaned offspring beginning at 3e6months of age to forage for food
on their own (Boinski & Fragaszy, 1989; Lyons et al., 1998). Initially,
brief intermittent separations studied in controlled experimental
conditions elicit distress peep-calls and increase plasma levels of
the stress hormone cortisol with partial habituation of these
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Hennessy, 1986). Later in life, squirrel monkeys exposed to inter-
mittent separations show fewer behavioral indications of anxiety,
diminished stress levels of cortisol, and enhanced sensitivity to
glucocorticoid feedback regulation of the hypothal-
amicepituitaryeadrenal (HPA) axis compared to squirrel monkeys
not exposed to prior separations (Lyons et al., 2009; Lyons et al.,
2010). Whereas severe forms of chronic stress impair HPA axis
regulation and induce anxiety in macaque monkeys (O'Connor &
Cameron, 2006; Sanchez, 2006), intermittent separations that
simulate naturally occurring but stressful conditions mimic the
effects of stress inoculation in humans.
In an earlier study of cognitive control conducted at 1.5 years of
age, stress inoculated squirrel monkeys exposed to prior intermit-
tent separations performed signiﬁcantly better than control squir-
rel monkeys not exposed to prior separations (Parker et al., 2005).
Performance on the same cognitive test in marmoset monkeys and
macaque monkeys is impaired by lesions of prefrontal cortex
(Diamond,1990; Dias et al., 1996;Wallis et al., 2001) but not lesions
of hippocampus (Diamond et al., 1989). In a different sample of
squirrel monkeys from those examined here, stress inoculation
early in life increased ventromedial prefrontal cortical volumes
compared to controls (Lyons et al., 2002). Larger volumes do not
reﬂect increased cortical thickness but instead represent surface
area expansion of ventromedial prefrontal cortex due to growth
and maturation of underlying white matter (Katz et al., 2009).
To determine whether improvements in cognitive control of
impulsivity continue on into adulthood, we tested a subset of the
same squirrel monkeys as those examined here using different
procedures at 3.5 years of age to assess inhibition of a motivated
pre-potent response (Parker et al., 2012). Stress inoculated squirrel
monkeys exposed to prior intermittent separations again per-
formed better than control squirrel monkeys not exposed to prior
separations (Parker et al., 2012). Moreover, performance at 3.5
years correlated with cognitive control measures collected at 1.5
years of age (Parker et al., 2012). These ﬁndings suggest that stress
inoculation early in life induces enduring trait-like transformations
in cognitive control of impulsivity.
Cognitive control of impulsive behavior is a complex function
mediated by multiple neural mechanisms. Larger ventromedial
prefrontal size in humans predicts diminished impulsivity (Matsuo
et al., 2009) and prefrontal cortical regions interact with striatal
dopamine systems to regulate cognitive control (Jentsch &
Pennington, 2014). Studies of rats, monkeys, and humans have
found that impulsive motivation for psychostimulant drugs is
associated with low striatal DRD2/3 measures (Dalley et al., 2011;
Nader et al., 2006; Triﬁlieff & Martinez, 2014; Volkow et al., 2011)
and high striatal DRD2/3 availability in humans has been linked to
resilience against addictions (Volkow et al., 2002; Volkow et al.,
2006). Pharmacological DRD2/3 agonists decrease impulsive
behavior in rats (Fernando et al., 2012) and improve reversal
learning as an index of cognitive control in humans dependent on
psychostimulant drugs (Ersche et al., 2011).
We found that DRD2/3 availability was greater in squirrel
monkey caudate and putamen compared to ventral striatum as
observed in PET studies of humans (Mawlawi et al., 2001) and other
non-human primates (Groman et al., 2011). DRD2/3 availability was
also greater in stress inoculated squirrel monkeys compared to no-
stress controls. Stress inoculation effects were greatest in ventral
striatum followed by caudate and putamen. Differences between
striatal regions in neuroanatomical connections and functions
(Haber & Knutson, 2010; Choi et al., 2012) support our ﬁnding that
enhanced cognitive control correlated with higher DRD2/3 avail-
ability in ventral striatum. Pharmacological mimicry of increased
DRD2/3 availability by stress inoculation may therefore provide anovel target for new treatments of psychiatric disorders in humans
that involve deﬁcits in cognitive control.
Our results should be interpreted in the context of potential
limitations. Findings from females may or may not hold true for
males. Behavioral measures of cognitive control were not collected
from all monkeys which limited the size of samples used for cor-
relations but allowed assessment of stress inoculation versus sub-
sequent testing effects. The [11C]raclopride PET radiotracer
primarily binds dopamine D2 receptors (Narendran et al., 2006) but
also D3 receptors in ventral striatum (Gurevich & Joyce, 1999) and
does not distinguish pre-versus post-synaptic locations. DRD2/3
BPND measures also reﬂect receptor availability and not receptor
densities because in vivo dopamine levels affect [11C]raclopride
binding (Laruelle, 2000). Nevertheless, in vivo PET measures of
DRD2/3 availability correlate with in vitro estimates of striatal
DRD2/3 densities in vervet monkeys (Groman et al., 2014). More-
over, cerebrospinal ﬂuid levels of the dopamine metabolite
homovanillic acid do not differ signiﬁcantly in stress inoculated
squirrel monkeys compared to controls (Parker et al., 2007). Lastly,
the search for drugs that mimic increased DRD2/3 signaling as a
target for new clinical interventions must contend with unwanted
side effects (Jentsch & Pennington, 2014).
5. Conclusions
We found stress inoculation and striatal region main effects for
DRD2/3 availability in squirrel monkeys. DRD2/3 availability was
greater in caudate and putamen compared to ventral striatum.
DRD2/3 availability in ventral striatum was also consistently
greater in stress inoculated squirrel monkeys compared to no-
stress controls. Squirrel monkeys exposed to stress inoculation in
the presence of their mother did not differ from squirrel monkeys
exposed to stress inoculation without maternal companionship.
Similar effects in different social contexts extend the generality of
our ﬁndings and together suggest that stress inoculation increases
striatal DRD2/3 availability as a correlate of cognitive control in
squirrel monkeys.
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